These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35985690)

  • 1. Analysis of Protein-Protein Interactions Identifies NECTIN2 as a Target of
    Thongsom S; Aksorn N; Petsri K; Roytrakul S; Sriratanasak N; Wattanathana W; Chanvorachote P
    Cancer Genomics Proteomics; 2022; 19(5):624-635. PubMed ID: 35985690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel c-Myc-Targeting Compound
    Sriratanasak N; Petsri K; Laobuthee A; Wattanathana W; Vinayanuwattikun C; Luanpitpong S; Chanvorachote P
    Mol Pharmacol; 2020 Aug; 98(2):130-142. PubMed ID: 32487733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NECTIN2 is a prognostic biomarker and potential therapeutic target in lung adenocarcinoma.
    Ando T; Ka M; Sugiura Y; Tokunaga M; Nakagawa N; Iida T; Matsumoto Y; Watanabe K; Kawakami M; Sato M; Kage H
    Respir Investig; 2024 Jul; 62(4):582-588. PubMed ID: 38678829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the Protein-Protein Interaction Network Identifying c-Met as a Target of Gigantol in the Suppression of Lung Cancer Metastasis.
    Aksorn N; Losuwannarak N; Tungsukruthai S; Roytrakul S; Chanvorachote P
    Cancer Genomics Proteomics; 2021; 18(3):261-272. PubMed ID: 33893079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phoyunnanin E inhibits migration of non-small cell lung cancer cells via suppression of epithelial-to-mesenchymal transition and integrin αv and integrin β3.
    Petpiroon N; Sritularak B; Chanvorachote P
    BMC Complement Altern Med; 2017 Dec; 17(1):553. PubMed ID: 29284478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum nectin-2 and nectin-4 are diagnostic in lung cancer: which is superior?
    Erturk K; Karaman S; Dagoglu N; Serilmez M; Duranyildiz D; Tas F
    Wien Klin Wochenschr; 2019 Sep; 131(17-18):419-426. PubMed ID: 31440821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovalitenone Inhibits the Migration of Lung Cancer Cells via the Suppression of AKT/mTOR and Epithelial-to-Mesenchymal Transition.
    Sanookpan K; Nonpanya N; Sritularak B; Chanvorachote P
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33530617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
    Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
    J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a.
    Wang S; Qiu M; Xia W; Xu Y; Mao Q; Wang J; Dong G; Xu L; Yang X; Yin R
    Oncotarget; 2016 Nov; 7(48):79736-79746. PubMed ID: 27806326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer.
    Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U
    BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arenobufagin, isolated from toad venom, inhibited epithelial-to-mesenchymal transition and suppressed migration and invasion of lung cancer cells via targeting IKKβ/NFκB signal cascade.
    Zhao J; Zhang Q; Zou G; Gao G; Yue Q
    J Ethnopharmacol; 2020 Mar; 250():112492. PubMed ID: 31866511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Acidic Tumor Microenvironment Affects Epithelial-Mesenchymal Transition Markers as Well as Adhesion of NCI-H358 Lung Cancer Cells.
    Riemann A; Rauschner M; Gießelmann M; Reime S; Thews O
    Adv Exp Med Biol; 2021; 1269():179-183. PubMed ID: 33966214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 14. Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of non‑small cell lung cancer via regulating GSK-3β/β-catenin signaling.
    Geng F; Jiang Z; Song X; Zhou H; Zhao H
    Int J Oncol; 2017 Dec; 51(6):1898-1908. PubMed ID: 29039479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of β-catenin and snail/slug in non-small cell lung carcinoma cells.
    Perumal E; So Youn K; Sun S; Seung-Hyun J; Suji M; Jieying L; Yeun-Jun C
    Lung Cancer; 2019 Apr; 130():25-34. PubMed ID: 30885348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isorhamnetin inhibited migration and invasion via suppression of Akt/ERK-mediated epithelial-to-mesenchymal transition (EMT) in A549 human non-small-cell lung cancer cells.
    Luo W; Liu Q; Jiang N; Li M; Shi L
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31467176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
    Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
    Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway.
    Shen M; Xu Z; Xu W; Jiang K; Zhang F; Ding Q; Xu Z; Chen Y
    J Exp Clin Cancer Res; 2019 Apr; 38(1):149. PubMed ID: 30961670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer.
    Kachroo P; Lee MH; Zhang L; Baratelli F; Lee G; Srivastava MK; Wang G; Walser TC; Krysan K; Sharma S; Dubinett SM; Lee JM
    J Exp Clin Cancer Res; 2013 Nov; 32(1):97. PubMed ID: 24274066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of Feiyanning on the expression of epithelial-mesenchymal factors in highly metastatic lung cancer cells 95-D].
    Zhao X; Wu Z; Xu Z; Wang Z; Wu J; Su W
    Zhongguo Fei Ai Za Zhi; 2011 Jun; 14(6):467-71. PubMed ID: 21645447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.